GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal

As the Chinese vaccines market undergoes a seismic shift marked by disappointing sales, GSK has extended—but with reduced volumes—an ongoing shingles vaccine partnership with local powerhouse Chongqing Zhifei Biological Products.